NCT/Study#
NCT04106167 /
FT-003
Long-Term, Non-Interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
